Utilizing a 3R tau fragment as a substrate, they achieved high sensitivity and specificity in differentiating the 3R-related Pick’s disease from 4R tauopathies (PSP, CBD, and AGD) and mixed 3R/4R tauopathies (AD and CTE). The gene discussed is MAPT; the disease is red-green color blindness.